Segment Information (Tables)

9 Months Ended

Sep. 30, 2012

Worldwide revenue by category was as follows:



	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2012		2011		2012		2011
	(Dollars in millions)
Revenue — to unaffiliated customers:
Pharmaceutical products
Neuroscience	$	1,815.8	$	2,488.0	$	5,544.0	$	7,547.1
Endocrinology	1,646.1		1,692.9		5,041.2		4,965.4
Oncology	791.7		817.8		2,442.4		2,483.5
Cardiovascular	650.9		630.1		1,936.4		1,852.5
Other pharmaceuticals	59.4		68.1		199.6		181.0
Total pharmaceutical products	4,963.9		5,696.9		15,163.6		17,029.5
Animal health	479.4		451.0		1,482.4		1,210.4
Total revenue	$	5,443.3	$	6,147.9	$	16,646.0	$	18,239.9

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details